M. Smeets

Long-term treatment of transfusional iron overload with the oral iron chelator deferiprone (L1): a Dutch multicenter trial

M. Kersten, G. Vreugdenhil, K. Roozendaal, 1996, Annals of Hematology.

Iron chelators may enhance erythropoiesis by increasing iron delivery to haematopoietic tissue and erythropoietin response in iron-loading anaemia.

R. Feelders, G. Vreugdenhil, H. G. van Eijk, 1993, Acta haematologica.

Improvement of erythropoiesis during treatment with deferiprone in a patient with myelofibrosis and transfusional hemosiderosis

R. Holdrinet, G. Vreugdenhil, M. Smeets, 1996, American journal of hematology.

New developments in the treatment of acute myeloid leukemia.

R. Raymakers, P. Muus, T. de Witte, 1999, Advances in experimental medicine and biology.